Qube Research & Technologies (QRT)’s Precigen PGEN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$18.9M	Buy	+2,208,964	New	+$14.5M	0.02%	1038
2023 Q1	–	Sell	-11,532	Closed	-$17.5K	–	2907
2022 Q4	$17.5K	Buy	+11,532	New	+$19.8K	﹤0.01%	2243
2022 Q3	–	Sell	-57,921	Closed	-$78K	–	2890
2022 Q2	$78K	Sell	57,921 -540,765	-90%	-$802K	﹤0.01%	2022
2022 Q1	$1.26M	Buy	598,686 +523,227	+693%	+$1.27M	0.01%	1048
2021 Q4	$280K	Sell	75,459 -22,995	-23%	-$99K	﹤0.01%	1834
2021 Q3	$491K	Buy	98,454 +81,796	+491%	+$471K	0.01%	1220
2021 Q2	$109K	Sell	16,658 -37,444	-69%	-$262K	﹤0.01%	1935
2021 Q1	$373K	Buy	+54,102	New	+$457K	0.01%	1342

Other funds holding PGEN

Patient Capital Management Baltimore, Maryland $3.15B AUM 29.14% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return

Occam Crest Management Darien, Connecticut $188M AUM 69.74% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PGEN Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Precigen (PGEN) in Q3 2026: 2,208,964 shares worth $18.9M. The stake represents 0.02% of the portfolio and ranks #1038 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in PGEN as recently as Q4 2022.

Qube Research & Technologies (QRT) first reported a position in PGEN in Q1 2021 and has held it in 8 quarters since. 183 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

Qube Research & Technologies (QRT) held 2,208,964 shares of Precigen worth $18.9M as of Q3 2026.
Precigen was a new Qube Research & Technologies (QRT) position in Q3 2026.
Precigen made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1038 holding.
Qube Research & Technologies (QRT) first reported a position in Precigen in Q1 2021 and has held it in 8 quarters since.
183 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.